Fluvoxamine: a $4 Antidepressant That Reduces COVID 19 Hospitalizations

Study Finds Cheap, Generic Antidepressant May Lower Severe COVIDПодробнее

Fluvoxamine - A $5 Antidepressant That Fights COVIDПодробнее

Antidepressant COVID-19 treatment shows promise in early study: FluvoxamineПодробнее

Daily Covid-19 Minute: FluvoxamineПодробнее

Antidepressant reduces hospitalisations and deathsПодробнее

Study Shows Widely-Available Antidepressant Significantly Reduces COVID HospitalizationПодробнее

Can the antidepressant 'fluvoxamine' reduce COVID-19 symptoms and hospitalizations?Подробнее

Fluvoxamine for COVID-19: A New Weapon in the Fight?Подробнее

Researchers say one type of antidepressant could help with COVID-19 symptomsПодробнее

UT researchers look at antidepressant as potential treatment for COVID-19 symptomsПодробнее

Fluvoxamine (Luvox) What you NEED to Know! #antidepressantsПодробнее

Fluvoxamine and COVID 19: what is the relationship? - IC@N ECHOПодробнее

No, SSRI Fluvoxamine isn’t approved for treating COVID-19Подробнее

The TOGETHER Study Shows that Fluvoxamine Reduces Risk of Prolonged HospitalizationПодробнее

Doctor explains antidepressant tested as a COVID-19 treatmentПодробнее

$4 antidepressant shows promise against early COVID-19 symptoms; more study neededПодробнее

Fluvoxamine as a Treatment for COVID-19?Подробнее

$4 antidepressant shows promise against early COVID-19 symptoms; more study neededПодробнее

Fluvoxamine Reduces Hospitalization Risk in High-Risk Patients (1 Minute Journal Club-ish) #shortsПодробнее